He said the department will continue with the planned phase 1 vaccination rollout using the Johnson & Johnson (J&J) vaccine instead of the Oxford-AstraZeneca vaccine.
“The J&J vaccine has proved to be effective against the 501Y.V2 variant and the necessary approval processes for use in SA are in progress,” said Mkhize.
He said the nationwide phase 1 vaccine rollout is expected to start next week, with the exact date to be announced by cabinet.
Subscribe to MultimediaLIVE here.
TimesLIVE
WATCH | ‘We will not waste the money’: Mkhize updates SA on ‘ineffective’ AstraZeneca vaccine
Health minister Zweli Mkhize hosted a public briefing on Wednesday morning to address the Oxford-AstraZeneca vaccine’s lack of effectiveness against the 501Y.V2 Covid-19 variant.
The minister said the outcomes of the efficacy studies “shocked everyone”.
He said the department will continue with the planned phase 1 vaccination rollout using the Johnson & Johnson (J&J) vaccine instead of the Oxford-AstraZeneca vaccine.
“The J&J vaccine has proved to be effective against the 501Y.V2 variant and the necessary approval processes for use in SA are in progress,” said Mkhize.
He said the nationwide phase 1 vaccine rollout is expected to start next week, with the exact date to be announced by cabinet.
Subscribe to MultimediaLIVE here.
TimesLIVE
Would you like to comment on this article?
Register (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Trending
Related articles
Latest Videos